Profile
| Metric | Value |
|---|---|
| Full Name | Vaxcyte, Inc. |
| Ticker | NASDAQ: PCVX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vaxcyte.com |
| Employees | 414 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $55.61 | |
| Price, 1D Change | +0.60% | |
| $7B | ||
| - | ||
| - | ||
| 0.77 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.80 | ||
| EPS, 1Y Change | +8.15% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.80 | ||
| EPS Estimate | -$5.19 | |
| EPS Est. Change | -36.52% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $55.61 | |
| Price Target | - | $110.00 |
| Price Tgt. Change | - | +97.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.49 | -$4.14 | -18.63% | |
| -$3.91 | -$3.80 | +2.84% | |
| -$5.19 | N/A | -36.52% | |
| -$6.22 | N/A | -63.52% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $21.43M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $55.61 | |
| $38.80 | ||
| SMA 200 vs Price | -30.22% | |
| $47.97 | ||
| SMA 50 vs Price | -13.75% | |
| 0.77 | ||
| $2.99 | ||
| 62.95 | ||
| 64.83% | ||
| 73.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.80 | ||
| -$15.85M | ||
| - | ||
| -$569.55M | ||
| - | ||
| -$463.93M | ||
| - | ||
| -$448.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 12.75 | ||
| 12.75 | ||
| - | ||
| - | ||
| 18.78 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.52 | ||
| -7.14 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $3.31B | ||
| $387.88M | ||
| $3.53B | ||
| $1.79B | ||
| $227.48M | ||
| $140.18M | ||
| $71.11M | ||
| $5.89M | ||
| $48.45M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $569.55M | ||
| $569.55M | ||
| $15.85M | ||
| $92.90M | ||
| $15.85M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$452.63M | ||
| -$2.01B | ||
| $2.45B | ||
| $119.16M | ||
| -$571.79M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| BTIG | → | |
| Goldman Sachs | ||
| Cantor Fitzgerald | ||
| Needham | → | |
| Needham | → | |
| Goldman Sachs | → | |
| B of A Securities | → | |
| Guggenheim | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with PCVX
FAQ
What is the ticker symbol for Vaxcyte, Inc.?
The ticker symbol for Vaxcyte, Inc. is NASDAQ:PCVX
Does Vaxcyte, Inc. pay dividends?
No, Vaxcyte, Inc. does not pay dividends
What sector is Vaxcyte, Inc. in?
Vaxcyte, Inc. is in the Healthcare sector
What industry is Vaxcyte, Inc. in?
Vaxcyte, Inc. is in the Biotechnology industry
What country is Vaxcyte, Inc. based in?
Vaxcyte, Inc. is headquartered in United States
When did Vaxcyte, Inc. go public?
Vaxcyte, Inc. initial public offering (IPO) was on June 12, 2020
Is Vaxcyte, Inc. in the S&P 500?
No, Vaxcyte, Inc. is not included in the S&P 500 index
Is Vaxcyte, Inc. in the NASDAQ 100?
No, Vaxcyte, Inc. is not included in the NASDAQ 100 index
Is Vaxcyte, Inc. in the Dow Jones?
No, Vaxcyte, Inc. is not included in the Dow Jones index
When was Vaxcyte, Inc. last earnings report?
Vaxcyte, Inc.'s most recent earnings report was on November 4, 2025
When does Vaxcyte, Inc. report earnings?
The next expected earnings date for Vaxcyte, Inc. is February 24, 2026
Data Sources & References
- PCVX Official Website vaxcyte.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1649094/000164909425000114/0001649094-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649094/000164909425000028/0001649094-25-000028-index.htm
- PCVX Profile on Yahoo Finance finance.yahoo.com/quote/PCVX
- PCVX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pcvx